Foley Partner David Rosen, chair of the firm’s FDA Regulatory Practice and co-chair of the Life Sciences Industry Team, will team up with Grant Thornton on December 6, 2018, to present “Hot Topics With the FDA and the Impact to Your Business,” a webinar geared towards life sciences executives.
From access to over-the-counter drugs to a crackdown on vaping and the opioid crisis, anyone watching the news can see that the list of FDA mega trends is increasing. Tackling compliance and enforcement isn’t enough. Forward-thinking life sciences executives consider the impact of these mega trends as they develop new strategies and tactics – while adjusting their current business model along the way.
Join this discussion with professionals who have spent the bulk of their careers working in parallel with the FDA as well as industry executives who will describe “lessons learned” and helpful tips.
- Describe how the FDA mega trends can impact your business and identify steps your company can consider to prepare for the outcome of these new regulations
- Examine how to be best prepared when engaging with the FDA and tips for expediting product development
- Identify enforcement areas and corrective and preventative actions
David Rosen, Partner, Foley & Larder LLP
Joseph Sapiente, Vice President, Quality Assurance and Regulatory Affairs, Hologic, Inc.
George Serafin, Healthcare and Life Sciences Industry Leader, Grant Thornton LLP
Continuing Professional Education (CPE) Credit
This program is recommended for 1.0 CPE credit.
Grant Thornton is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org.